Metropolitan Life Insurance Company (MetLife)’s ACELYRIN SLRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q2
Sell
-3,931
Closed -$26.5K 1792
2024
Q1
$26.5K Buy
3,931
+1,927
+96% +$13K ﹤0.01% 1720
2023
Q4
$15K Hold
2,004
﹤0.01% 2039
2023
Q3
$20.4K Buy
+2,004
New +$20.4K ﹤0.01% 1890